×

Niklas Carlén Appointed New CFO at Stille

Stille AB (publ) informs about a change in group management and the appointment of a new CFO.

Stille has appointed Niklas Carlén as the new CFO for the company and a member of the group management. Niklas Carlén has a Masters Degree of Science in Business Administration and Economics from Örebro University. He has for the past 15 years worked as a CFO at Calix, Swecon and TOOLS Sverige, most recently as the CFO at Eskilstuna Strängnäs Energi och Miljö.

I am very pleased with welcoming Niklas to Stille and as part of the group management. Niklas is highly competent with 15 years in the role as a CFO, and will greatly strengthen our financial department, says Stille’s CEO Hanna Ernestam Wilkman.

I look forward to working with Hanna and the rest of Stille’s employees to build a bigger, stronger and better company, says Niklas Carlén, new CFO at Stille.

Niklas will start his position as CFO at Stille on June 1st, 2020,

Torshälla, June 1st 2020.

Attachments

Pressrelease - New CFO Niklas Carlén.pdf

For more information, please contact:

Hanna Ernestam Wilkman
CEO
+46 (0)72 402 10 88 | hanna.e.wilkman@stille.se

STILLE AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures, the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality.

The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser. Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. This information is such information that Stille AB is obliged to disclose according to the EU’s market abuse regulation.

For more information about Stille visit www.stille.se


Subscribe to our news!

Enter your details and get the latest news straight to your inbox